| dc.contributor.author |
Wang, Zhaolin |
|
| dc.contributor.author |
Junker, Anna |
|
| dc.date.accessioned |
2026-09-22T12:06:03Z |
|
| dc.date.available |
2026-09-22T12:06:03Z |
|
| dc.date.issued |
2026 |
|
| dc.identifier.issn |
1354-3776 |
|
| dc.identifier.uri |
http://hdl.handle.net/10900/183550 |
|
| dc.language.iso |
en |
de_DE |
| dc.publisher |
Abingdon : Taylor & Francis Ltd |
de_DE |
| dc.relation.uri |
http://dx.doi.org/10.1080/13543776.2026.2638344 |
de_DE |
| dc.subject.ddc |
540 |
de_DE |
| dc.subject.ddc |
610 |
de_DE |
| dc.title |
5'-Ectonucleotidase (CD73) inhibitors: a patent review (2021-present) |
de_DE |
| dc.type |
Article |
de_DE |
| utue.quellen.id |
20260422000000_00501 |
|
| utue.publikation.seiten |
389-400 |
de_DE |
| utue.personen.roh |
Wang, Zhaolin |
|
| utue.personen.roh |
Junker, Anna |
|
| dcterms.isPartOf.ZSTitelID |
Expert Opinion on Therapeutic Patents |
de_DE |
| dcterms.isPartOf.ZS-Issue |
4 |
de_DE |
| dcterms.isPartOf.ZS-Volume |
36 |
de_DE |
| utue.fakultaet |
04 Medizinische Fakultät |
de_DE |